期刊
JOURNAL OF MAGNETIC RESONANCE IMAGING
卷 39, 期 6, 页码 1588-1594出版社
WILEY
DOI: 10.1002/jmri.24319
关键词
DWI; MRS; TRA-8; carboplatin; triple-negative breast cancer
资金
- Komen Promise Grant
- NIH [2P30CA013148]
PurposeTo assess the early response of triple-negative breast-cancer (TNBC) following TRA-8 and carboplatin therapy using DWI and MRS in 2LMP and SUM159 mouse models. Materials and MethodsFour groups (n=5/group) of each model were untreated or treated with carboplatin, TRA-8, and combination, respectively. DWI and MRS were applied on 0, 3, and 7 days after therapy initiation, and all tumors were collected thereafter for terminal deoxynucleotidyl transferase mediated dUTP nick end labeling (TUNEL) staining. The changes in intratumoral apparent diffusion coefficient (ADC) and fat-water ratios (FWRs) were compared with tumor volume changes and apoptotic cell densities. ResultsMean ADC values of 2LMP and SUM159 tumors significantly increased 44% and 37 +/- 11% during 7 days of combination therapy, respectively, as compared to control groups (P<0.05). Similarly, mean FWRs of 2LMP and SUM159 tumors significantly increased 102 +/- 30% and 126 +/- 52%, respectively, for 7 days of combined treatment (P<0.05). The changes of the mean ADC values for 3 days (or FWRs for 7 days) were linearly proportional to either the mean volume changes or apoptotic cell densities in both models. ConclusionDWI and MRS assessed the early tumor response to TRA-8 and carboplatin in TNBC mouse models. J. Magn. Reson. Imaging 2014;39:1588-1594. (c) 2013 Wiley Periodicals, Inc.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据